Dear Editor,
The WAKE-UP trial screened patients in the unknown time window after stroke onset for the presence of a DWI-FLAIR mismatch. 1 Since perfusion-weighted imaging (PWI) was not mandatory, the pattern of a total mismatch, i.e. a negative DWI together with a positive PWI lesion, remained undetected in the primary analysis. [2] [3] [4] [5] [6] In a post-hoc analysis, we investigated the incidence of the total mismatch profile in patients enrolled in the WAKE-UP trial. For patients with available PWI, we calculated DWI and PWI lesion volumes with RAPID (iSchemaView, Menlo Park, CA). Of the 1362 patients enrolled, PWI was available in 343 (25%). Of these, only three (0.9%) had a total mismatch, caused by an M2 occlusion of the middle cerebral artery ( Figure 1 ). Less than 1% of patients had a total mismatch. The absence of a DWI lesion in patients presenting with stroke-like symptoms should prompt the clinician to consider stroke mimics. Additional PWI can guide physicians to determine a vascular etiology for the neurological symptoms, which can be confirmed by identifying a vessel occlusion on magnetic resonance angiography. Apart from stroke mimics, early imaging after stroke onset, stroke in the posterior circulation, and stroke caused by small vessel disease can all lead to DWI negativity. 7 None of these were present in the three total mismatch patients. The confirmation of a vessel occlusion excluded early (partial) reperfusion as a possible explanation for DWI negativity.
Since randomization in the WAKE-UP trial was based on the presence of the DWI-FLAIR mismatch, 1 these patients were not randomized and assigned to a particular treatment arm. Given the infinite PWI-DWI mismatch ratio, they might have been ideal candidates for reperfusion treatment. The natural course and benefit from treatment in these patients is not well known. Withholding reperfusion treatment might therefore be hazardous as long as the fate of the hypoperfused tissue remains uncertain. [2] [3] [4] [5] [6] When evaluating patients for the DWI-FLAIR mismatch, PWI can provide additional information to ensure the most comprehensive patient selection, although the total mismatch pattern may be uncommon.
Declaration of conflicting interests
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Claus Z Simonsen: Funded by a grant from Novo Nordisk Foundation. Go¨tz Thomalla: Consulting fees from Acandis, grant support, and lecture fees from Bayer, lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, and Daiichi Sankyo, and consulting fees and lecture fees from Stryker.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The WAKE-UP trial received funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement no. 278276.
ORCID iD
Lauranne Scheldeman https://orcid.org/0000-0002-5263-3550 Anke Wouters https://orcid.org/0000-0001-5229-2699
